InvestorsHub Logo
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

Re: XenaLives post# 9397

Monday, 04/01/2019 3:54:42 PM

Monday, April 01, 2019 3:54:42 PM

Post# of 21541
NTRP hands-down leader.

AVXL...not so much.

2-73 for Parkinson's? A graveyard for drug trials. Good luck with that trial. Maybe the placebos are outperforming and asking for extension? Won't know until the trial reads out.

Good luck using a drug (2-73) that is in the same class as drugs (S1R) that have failed in placebo-controlled Alzheimer's trials.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News